6 minute read
Dec. 21, 2023

Where Are They Now? Clinical Updates from Past MOTM for TTR, FXIa, GLP-1R Modulators and More

Drug Hunter Team

Last November saw several notable updates for molecules we previously covered on Drug Hunter. These updates ranged from positive Ph. III results and NDA submission to failed clinical trials and discontinuation, for TTR, FXIa, GLP-1R modulators, and more. In case you missed it, this article is a round-up of these clinical updates from Nov. ’23.



Other articles you may be interested in